Drug Attitude, Insight, and Patient's Knowledge About Prescribed Antipsychotics in Schizophrenia: A Cross-Sectional Survey.
Nobuhiro NagaiHideaki TaniKazunari YoshidaPhilip GerretsenTakefumi SuzukiSaeko Ikai-TaniMasaru MimuraHiroyuki UchidaPublished in: Neuropsychiatric disease and treatment (2020)
Better insight into illness and treatment, lower illness severity, longer illness duration, and possibly greater knowledge about the therapeutic effects of medications may lead to better attitudes towards pharmacotherapy among patients with schizophrenia, which has an important implication for this typically chronic mental condition requiring long-term antipsychotic treatment to sustain stability.